]>
IRCT20140305016858N5 IRCT 2021-06-19 Mazandaran University of Medical Sciences Evaluation of the effectiveness of interalipid infusion for patients with a history of 2 unsuccessful embryo transfers Evaluation of the effectiveness of interalipid infusion for patients with a history of 2 unsuccessful embryo transfers 2021-05-22 anticipated 80 Complete https://irct.ir/trial/55349 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: -, Randomization description: For this study, 80 sealed envelopes were prepared which were divided into two groups A and B and the relevant expert selected one envelope for each patient and the patient was randomly placed in the control or intervention group. 3 Recurrent implantation failler. Intervention 1: Control group:Intervention group (Intralipid receptor): Intralipid receptor 20% solution in 250 cc of sterile saline, which is administered within two hours. Once between days 4 to 9 of ovarian stimulation and again on day 7 with a positive pregnancy test. Intervention 2: Control group: Control group: does not receive interalipid. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no more information
public Dr Sepideh Peyvandi
Amir Mazandarani St., Imam Khomeini Hospital (RA) Infertility Clinic
Sari Iran (Islamic Republic of) 4816633131 +98 11 3336 1700 drspeyvandi@mazums.ac.ir Mazandaran University of Medical Sciences scientific Dr Sepideh Peyvandi
Amir Mazandarani St., Imam Khomeini Hospital Infertility Clinic
Sari Iran (Islamic Republic of) 4816633131 009833361700-4 drspeyvandi@mazums.ac.ir Mazandaran University of Medical Sciences Iran (Islamic Republic of) Patients who have a history of 2 embryo transfers are sampled. Patients who are over 18 to 40 years old and have the necessary criteria for the IVF process All mothers with a history of infertility 18 years 40 years Female Mothers with dangerous chromosomal abnormalities Mothers with dangerous abnormalities of antiphospholipid syndrome or positive thrombophilia test Mothers with endocrine disorders Mothers with hyperlipidemia disorders Mothers who were allergic to eggs and their products Mothers over 40 years old N98.9 Complication associated with artificial fertilization, unspecified Other Other Control group:Intervention group (Intralipid receptor): Intralipid receptor 20% solution in 250 cc of sterile saline, which is administered within two hours. Once between days 4 to 9 of ovarian stimulation and again on day 7 with a positive pregnancy test. Control group: Control group: does not receive interalipid Positive pregnancy test. Timepoint: Two weeks after transfer. Method of measurement: In Imam Khomeini Infertility Center, pregnancy test is performed by ELISA method. Record fetal heart rate at 6 weeks of gestation. Timepoint: Six weeks of pregnancy. Method of measurement: sonography. Mazandaran University of Medical Sciences Approved 2020-04-29 Ethics Committee of Mazandaran University of Medical Sciences Sari Amir Mazandarani Blvd., Imam Khomeini Hospital, Department of Obstetrics and Gynecology, second floor Sari Mazandaran Iran (Islamic Republic of)